Is There Still a Role for Sulfonylureas in Type 2 Diabetes?

Brian Tomlinson; Paul Chan; Christopher Wai Kei Lam

doi:10.2174/1875692118666211021164840

Is There Still a Role for Sulfonylureas in Type 2 Diabetes?

Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	58-59
Number of pages	2
Journal	Current Pharmacogenomics and Personalized Medicine
Volume	18
Issue number	2
DOIs	https://doi.org/10.2174/1875692118666211021164840
Publication status	Published - Aug 2021

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics
Pharmacology
Genetics(clinical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2174/1875692118666211021164840

Cite this

@article{852ed590acc7406786761b626ee5a00a,

title = "Is There Still a Role for Sulfonylureas in Type 2 Diabetes?",

author = "Brian Tomlinson and Paul Chan and Lam, {Christopher Wai Kei}",

year = "2021",

month = aug,

doi = "10.2174/1875692118666211021164840",

language = "English",

volume = "18",

pages = "58--59",

journal = "Current Pharmacogenomics and Personalized Medicine",

issn = "1875-6921",